Analgesics Market on the Rise Expected to Surpass US$ 132.0 Million by 2033 with a Remarkable 4.2% CAGR | FMI Inc.

According to FMI reports, the global Analgesics Market can soar at a rate CAGR of 4.2% from 2023-2033. The net worth of the market share of the analgesics industry is predicted to go from US$ 87.3 Mn in 2023 to over US$ 132.0 Mn by 2033.

People with acute, chronic diseases such as heart disease, cancer, diabetes, stroke, and arthritis, as well as infectious diseases like gastrointestinal, respiratory, and neurological ailments, are becoming increasingly common. Painkiller demand is on the rise as these diseases become more prevalent.

The geriatric population increase is a major factor in the increased demand for analgesics, major pharmaceutical companies manufacture and distribute analgesics, and consumer healthcare expenditure is rising.

Get a Sample Report to learn about recent in the Analgesics industry observed by FMI. @ 
https://www.futuremarketinsights.com/reports/sample/rep-gb-1306

Clinical trials will continue to be conducted to evaluate the safety and efficacy of a wide range of therapeutic drugs, increasing the analgesics market. Furthermore, analgesics market trends are primarily driven by the growing number of elderly people, cardiovascular diseases, cancer, and arthritis.

This is driven by technological advancements in the pharmaceutical industry that allow advanced analgesic drugs to be manufactured, which will create remunerative opportunities for the analgesics market forecast period.

Key Takeaways from the Analgesics Market Study

-The global analgesics market expanded at 6%CAGR over 2017-2022.
-The U.S. dominates the North American analgesics market with a total share of 5% in 2022 and is projected to continue exhibiting high demand registering a CAGR of 3.5%.
-Surgical pain holds a revenue share of 3% in 2023 and is projected to continue accounting for over half of sales in the market by 2033.
-By drug type, the demand for opioids is projected to increase at a CAGR of 8% during the forecast period.
-Based on distribution channels, hospital pharmacies led the analgesics market with more than 1% market share with a CAGR of 5.4% in 2023.
-The analgesics market is expected to increase at a notable CAGR of 4.2%.

Competitive Landscape for the Analgesics Market

In the development of non-opioid or non-addictive pain management formulations, key players are focusing on novel and innovative approaches. Manufacturers are expanding their markets, launching new products, and receiving approvals to further strengthen their position in the market.

Pfizer Inc., Sun Pharmaceutical Industries, Inc., Sanofi SA, AbbVie Inc. (Allergan plc), Teva Pharmaceuticals, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Inc. [Johnson & Johnson], Endo Pharmaceuticals Inc., Purdue Pharmaceuticals L.P., Assertio Therapeutics, Inc., Mallinckrodt Pharmaceuticals, Bayer AG, GlaxoSmithKline plc., Bausch Health Companies Inc., Novartis AG, and others, the market is growing and establishing a strong global presence.

Enrich your thinking with our comprehensive methodology now. @
https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1306

Recent Developments in the Analgesics Market

-ZYNRELEF was launched by Heron Therapeutics Inc. in July 2021. It is an extended-release product designed for soft tissue or periarticular application and provides analgesia for up to 72 hours following a bunionectomy, inguinal herniorrhaphy, or total knee replacement.
-In January 2020, Novartis AG completed its acquisition of The Medical Company. This acquisition provided Novartis AG with new opportunities to treat disability and prevent death.
-It was announced in May 2020 that Assertio Therapeutics, Inc. merged with Zyla -Life Sciences. This merger created a growing pharmaceutical company with neurology, inflammation, and pain products.
-By expanding safe medication disposal kiosks to an additional 900 Walgreens stores in October 2017, Pfizer Inc., AmerisourceBergen, Blue Cross Blue Shield -Association, and Prime Therapeutics will join Walgreens (one of the nation's largest drugstore chains) to fight the national opioid abuse crisis.
-A pain relief spray called Volini Maxx was launched by Sun Pharma in August 2018.

Analgesics Market Segmentation by Category

By Drug Class:

-Opioids
-NSAIDs
-Local Anesthetics
-Acetaminophen

By Indication:

-Surgical Pain
-Cancer Pain
-Neuropathic Pain

By Route of Administration:

-Oral
-Parenteral
-Transdermal

By Distribution Channel:

-Hospital Pharmacies
-Retail Pharmacies
-Drug Store
-Clinics
-Others

 >Author

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Access Report, Gain Complete Understanding: @
https://www.futuremarketinsights.com/reports/analgesics-market

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

This release was published on openPR.